FindTrial
Sign In

Clinical observation of long-snake moxibustion combined with letrozole in the treatment of endometrial receptivity in PCOS patients with spleen and kidney yang deficiency

Clinical observation of long-snake moxibustion combined with letrozole in the treatment of endometrial receptivity in PCOS patients with spleen and kidney yang deficiency

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038278
Enrollment
Unknown
Registered
2020-09-15
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

Trial Group:long-snake moxibustion combined with letrozole
Control Group :letrozole

Sponsors

Nanchang Hongdu Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of PCOS; 2. Patients aged 20-40 years who voluntarily participated in the clinical trial and signed the informed consent form; 3. Patients with stable vital signs and need for pregnancy preparation; 4. Patients who have good compliance, cooperate with treatment and nursing, and have no special bad habits.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, brain, liver, kidney, hematopoietic system, endocrine system, immune system and other serious primary diseases, and patients with mental illness, severe diabetes mellitus and tumor; 2. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Ovulation status;The thickness, shape and arterial blood flow of the endometrium after ovulation;Pregnancy;—

Countries

China

Contacts

Public ContactGuo Rong

Nanchang Hongdu Hospital of TCM

875156388@qq.com+86 18724886642

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026